InvestorsHub Logo
Followers 15
Posts 646
Boards Moderated 0
Alias Born 04/21/2014

Re: rayovac812 post# 89667

Saturday, 03/14/2015 6:03:52 PM

Saturday, March 14, 2015 6:03:52 PM

Post# of 278154
I do agree that there is a very good possibility that MS may be licensed by another company for medical and other uses. Kim did state in the 2012 conference call:

I am open to a spin off it if would be in the best interests of the shareholders, but I do not envision that happening in the immediately foreseeable future. We are still a small company, and we are stronger together than we would be broken apart.


Since the approval for medical uses of anything is a long and arduous process, i could easily see Kim creating a spin-off company when he gets to that point to minimize the cost to KBLB.

I do agree that Kim and Jon need to focus on the mundane first and worry about Gen 3 fiber development after. From the same conference call:

The generation three technology, which we define as including customizable fibers and fibers which incorporate unique attributes, such as antibiotics, is next in the R & D rotation after the development of Gen 2.



How far along he is in the development of Gen 2, or pure spider silk, is still unknown. I mentioned in an earlier post that I suspected that Big Red may end up becoming SpiderPillar. That old conference call reinforces this with:

And then on to generation two, I would characterize our development of the generation II pure spider silk fiber as being in an advanced state of development. It is the primary, but not exclusive, area of our R & D focus during the second quarter. We are applying some very powerful technology and, of course, our own insight to bear on this, and, certainly Zinc Finger Nuclease plays an important roll here.


Advanced stage of development in 2012 should mean beginning ramp up to commercialization in the near future which should ideally mean full commercialization in 2017 or so with no issues. This may be accelerated by increased funding due to MS commercialization and a dedicated sericulture facility.

That Cocoon Biotech company is news to me. Thanks for posting it. Just a quick glance over the website shows that they are using standard silk. They may be processing it to give it better properties or maybe plan to eventually alter the silkworms, though. I noticed that David Kaplan is one of their advisors, so it would be a possibility. Just standard silk properties is a little weak compared to what would be required for tendon replacement or sutures.

I know for a fact that Kim is not the only one keeping secrets. There are plenty of scientists out there that are working on new, advanced methods for spider silk production to eventually create their own company or license it out mand get in on the imminant new revolution in biofibers and other biomaterials.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent KBLB News